Kembali
KLBF - Kalbe Farma

KLBF – Allocating IDR1 tn capex to increase production capacity

23 Mei 2025

KLBF – Allocating IDR1 tn capex to increase production capacity Kalbe Farma (KLBF) has allocated capex of IDR1 tn for asset maintenance and production capacity expansion, including through its subsidiary, Global Onkolab Farma's cancer drug factory. Previously, KLBF had just distributed a cash dividend of IDR1.7 tn, or IDR36 per share. (Source : Bisnis Indonesia)

Related Research

Healthcare
KLBF - 9M25 results came in-line on solid 3Q25 sales growth
Andre Suntono 31 Oktober 2025 Lihat Detail
Consumer
KLBF - Performa solid pada kuartal pertama tahun 2022
Winny Rahardja 10 Mei 2022 Lihat Detail
Consumer
KLBF - Expects a Brighter 24F, after a weak 23f
Andre Suntono 20 Maret 2024 Lihat Detail